Drew Moghanaki/X
Jun 22, 2025, 19:42
Drew Moghanaki Shared A Systematic Review and Meta-Analysis Comparing Surgery vs SABR for Adrenal Metastases
Drew Moghanaki, Chief Medical Officer at Respirati and Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at David Geffen School of Medicine at UCLA, shared a post on X:
“Excited to be a part of this collaboration with friends and colleagues in Amsterdam.
It isn’t inspired entirely to advance SABR in place of surgery; instead, it is about identifying how often adrenalectomies end up with positive margins and local recurrence. The preliminary data shows it happens >50% of the time.”
More posts featuring Drew Moghanaki on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 22, 2025, 17:24
Jun 22, 2025, 14:31